$80,000 of GENEDX LLC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage."
You can find more data on corporate lobbying on Quiver Quantitative.
WGS Insider Trading Activity
WGS insiders have traded $WGS stock on the open market 49 times in the past 6 months. Of those trades, 3 have been purchases and 46 have been sales.
Here’s a breakdown of recent trading of $WGS stock by insiders over the last 6 months:
- CAPITAL, LLC CASDIN sold 500,000 shares for an estimated $60,451,950
- KATHERINE STUELAND (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 19 sales selling 58,341 shares for an estimated $5,727,058.
- KEITH A. MEISTER has made 3 purchases buying 100,000 shares for an estimated $5,600,994 and 0 sales.
- JASON RYAN has made 0 purchases and 7 sales selling 39,222 shares for an estimated $4,995,800.
- KEVIN FEELEY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 19 sales selling 24,750 shares for an estimated $2,437,370.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
WGS Hedge Fund Activity
We have seen 138 institutional investors add shares of WGS stock to their portfolio, and 113 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 18,848,488 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,739,903,927
- FMR LLC removed 2,630,629 shares (-94.2%) from their portfolio in Q2 2025, for an estimated $242,833,362
- PENTWATER CAPITAL MANAGEMENT LP added 1,188,000 shares (+3712.5%) to their portfolio in Q2 2025, for an estimated $109,664,280
- UBS GROUP AG added 949,579 shares (+1821.2%) to their portfolio in Q2 2025, for an estimated $87,655,637
- CORVEX MANAGEMENT LP added 584,848 shares (+23.6%) to their portfolio in Q2 2025, for an estimated $53,987,318
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 533,383 shares (+105.9%) to their portfolio in Q2 2025, for an estimated $49,236,584
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 442,414 shares (+37.2%) to their portfolio in Q2 2025, for an estimated $40,839,236
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WGS Analyst Ratings
Wall Street analysts have issued reports on $WGS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 09/11/2025
- Guggenheim issued a "Buy" rating on 06/30/2025
- Jefferies issued a "Buy" rating on 05/09/2025
- TD Securities issued a "Buy" rating on 05/01/2025
To track analyst ratings and price targets for WGS, check out Quiver Quantitative's $WGS forecast page.
WGS Price Targets
Multiple analysts have issued price targets for $WGS recently. We have seen 5 analysts offer price targets for $WGS in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- David Westenberg from Piper Sandler set a target price of $140.0 on 09/11/2025
- Brandon Couillard from Wells Fargo set a target price of $95.0 on 07/30/2025
- Subbu Nambi from Guggenheim set a target price of $115.0 on 06/30/2025
- Tycho Peterson from Jefferies set a target price of $80.0 on 05/09/2025
- Dan Brennan from TD Securities set a target price of $110.0 on 05/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
